Old Web
English
Sign In
Acemap
>
authorDetail
>
Ken Kowalski
Ken Kowalski
Pfizer
Population
Medicine
Diabetes mellitus
Clinical trial
Internal medicine
7
Papers
130
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Making Better Dose Decisions: Using Exposure‐Response Modeling to Integrate Efficacy Outcome of Two Phase 2b Clinical Trials of Ubrogepant for Migraine Treatment
2019
Clinical and Translational Science
Chi-Chung Li
Tiffini Voss
Ken Kowalski
Bei Yang
Huub-Jan Kleijn
Christopher Jones
Rolien Bosch
David Michelson
Matthew DeAngelis
Yang Xu
Iris Xie
Prajakti A. Kothare
Show All
Source
Cite
Save
Citations (2)
Population PK Analyses of Ubrogepant (MK‐1602), a CGRP Receptor Antagonist: Enriching In‐Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling
2018
The Journal of Clinical Pharmacology
Chi‐Chung Li
Marissa Dockendorf
Ken Kowalski
Bei Yang
Yang Xu
Iris Xie
Huub-Jan Kleijn
Rolien Bosch
Christopher Jones
Bob Thornton
Eugene E. Marcantonio
Tiffini Voss
Kevin P. Bateman
Prajakti A. Kothare
Show All
Source
Cite
Save
Citations (22)
Population Modeling Is a Critical Element of Bridging Pharmacokinetic Data From Dried Blood Spot and Plasma Across Clinical Programs
2014
Marissa Dockendorf
Ken Kowalski
B. Yang
L. Ma
Huub-Jan Kleijn
Rolien Bosch
M. Forman
G. Marcantonio
Tiffini Voss
D. Jaworowicz
J. Passarell
Kevin P. Bateman
Julie A. Stone
Prajakti A. Kothare
Show All
Source
Cite
Save
Citations (0)
Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degeneration.
2012
The Journal of Clinical Pharmacology
Anthony S. Basile
Matt Hutmacher
Dana J. Nickens
Jace Nielsen
Ken Kowalski
Lloyd R. Whitfield
Oishi Masayo
Masami Nakane
Show All
Source
Cite
Save
Citations (23)
1